Novavax COVID-19 Vaccine Associated With Heart Inflammation: Study

According to a recent study, more cases of heart inflammation than expected have been seen in people who received the COVID-19 vaccination from Novavax.

According to Spanish researchers, 61 incidences of myocarditis, pericarditis, or both after receiving a Novavax vaccination were documented in the World Health Organization's vaccine safety database up through August 23, 2022.

The researchers determined that the number of post-vaccination cases was larger than anticipated using pre-pandemic rates of cardiac inflammation in the general population.

Providing odds ratios greater than one indicates a higher rate than anticipated. The ratio was 5.2 for myocarditis following the Novavax vaccination. The figure for pericarditis was 24.75. It was 14.4 for myopericarditis, or both conditions at once.

The Pfizer and Moderna COVID-19 vaccines, which use messenger RNA (mRNA) technology, are known to cause heart inflammation as a side effect; however, no information has been gather...

Limited Time

Full Access

$10
Monthly

Included:

  • Access to All Articles.
  • One Plan. No Tiers.
  • No Ads.
  • Cancel anytime.
register now

 
Do you have a tip or sensitive material to share with GGI? Are you a journalist, researcher or independent blogger and want to write for us? You can reach us at [email protected].